- Home
- DSGR vs PCRX Comparison
DSGR vs PCRX Comparison
Compare DSGR & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGR
- PCRX
- Stock Information
- Founded
- DSGR 1952
- PCRX 2006
- Country
- DSGR United States
- PCRX United States
- Employees
- DSGR N/A
- PCRX N/A
- Industry
- DSGR Industrial Machinery/Components
- PCRX Biotechnology: Pharmaceutical Preparations
- Sector
- DSGR Industrials
- PCRX Health Care
- Exchange
- DSGR Nasdaq
- PCRX Nasdaq
- Market Cap
- DSGR 1.4B
- PCRX 1.1B
- IPO Year
- DSGR N/A
- PCRX 2011
- Fundamental
- Price
- DSGR $28.60
- PCRX $24.89
- Analyst Decision
- DSGR Buy
- PCRX Buy
- Analyst Count
- DSGR 2
- PCRX 9
- Target Price
- DSGR $43.00
- PCRX $30.67
- AVG Volume (30 Days)
- DSGR 52.1K
- PCRX 839.4K
- Earning Date
- DSGR 05-01-2025
- PCRX 05-06-2025
- Dividend Yield
- DSGR N/A
- PCRX N/A
- EPS Growth
- DSGR N/A
- PCRX N/A
- EPS
- DSGR N/A
- PCRX N/A
- Revenue
- DSGR $1,804,104,000.00
- PCRX $700,966,000.00
- Revenue This Year
- DSGR $14.79
- PCRX $9.37
- Revenue Next Year
- DSGR $4.44
- PCRX $11.30
- P/E Ratio
- DSGR N/A
- PCRX N/A
- Revenue Growth
- DSGR 14.88
- PCRX 3.85
- 52 Week Low
- DSGR $27.30
- PCRX $11.16
- 52 Week High
- DSGR $41.47
- PCRX $31.67
- Technical
- Relative Strength Index (RSI)
- DSGR 44.99
- PCRX 54.83
- Support Level
- DSGR $27.30
- PCRX $23.93
- Resistance Level
- DSGR $28.90
- PCRX $25.88
- Average True Range (ATR)
- DSGR 0.81
- PCRX 0.91
- MACD
- DSGR 0.00
- PCRX 0.12
- Stochastic Oscillator
- DSGR 48.33
- PCRX 73.39
About DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education, and medical industries.
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.